A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/19452245

Download in:

View as

General Info

PMID
19452245